LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Crescent Biopharma, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCBIO
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CBIO COVERAGE

What’s moving Crescent Biopharma, Inc. now

Current reporting with the operating signal separated from the noise.

01
Crescent Biopharma, Inc.: Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to ...

Crescent Biopharma, Inc.: Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to ...

Investors are testing whether Crescent Biopharma, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CBIO filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-07-30 · Period 2026-06-30SEC ↗10-Q/AQuarterly financial reportFiled 2026-06-22 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-30SEC ↗8-KMaterial company eventFiled 2026-07-15 · Period 2026-07-14SEC ↗8-KMaterial company eventFiled 2026-07-14 · Period 2026-07-14SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-21 · Period 2026-06-02SEC ↗EFFECTOfficial SEC filingFiled 2026-07-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Crescent Biopharma, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.